Segui
Marija Buljan
Marija Buljan
Group Leader at Empa
Email verificata su empa.ch
Titolo
Citata da
Citata da
Anno
Classification of intrinsically disordered regions and proteins
R Van Der Lee, M Buljan, B Lang, RJ Weatheritt, GW Daughdrill, ...
Chemical reviews 114 (13), 6589-6631, 2014
22042014
Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes
JK White, AK Gerdin, NA Karp, E Ryder, M Buljan, JN Bussell, J Salisbury, ...
Cell 154 (2), 452-464, 2013
5542013
Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks
M Buljan, G Chalancon, S Eustermann, GP Wagner, M Fuxreiter, ...
Molecular cell 46 (6), 871-883, 2012
4422012
Alternative splicing of intrinsically disordered regions and rewiring of protein interactions
M Buljan, G Chalancon, AK Dunker, A Bateman, S Balaji, M Fuxreiter, ...
Current opinion in structural biology 23 (3), 443-450, 2013
2172013
Structural polymorphism in the N-terminal oligomerization domain of NPM1
DM Mitrea, CR Grace, M Buljan, MK Yun, NJ Pytel, J Satumba, A Nourse, ...
Proceedings of the National Academy of Sciences 111 (12), 4466-4471, 2014
1882014
The evolution of protein domain families
M Buljan, A Bateman
Biochemical Society Transactions 37 (4), 751-755, 2009
1502009
Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells
Y Liu, C Borel, L Li, T Müller, EG Williams, PL Germain, M Buljan, T Sajic, ...
Nature communications 8 (1), 1212, 2017
1382017
Quantifying the mechanisms of domain gain in animal proteins
M Buljan, A Frankish, A Bateman
Genome biology 11, 1-15, 2010
1162010
Kinase interaction network expands functional and disease roles of human kinases
M Buljan, R Ciuffa, A van Drogen, A Vichalkovski, M Mehnert, ...
Molecular cell 79 (3), 504-520. e9, 2020
1012020
Molecular principles of gene fusion mediated rewiring of protein interaction networks in cancer
NS Latysheva, ME Oates, L Maddox, T Flock, J Gough, M Buljan, ...
Molecular cell 63 (4), 579-592, 2016
652016
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework
G Glusman, PW Rose, A Prlić, J Dougherty, JM Duarte, AS Hoffman, ...
Genome medicine 9, 1-10, 2017
612017
Quantitative proteome landscape of the NCI-60 cancer cell lines
T Guo, A Luna, VN Rajapakse, CC Koh, Z Wu, W Liu, Y Sun, H Gao, ...
Iscience 21, 664-680, 2019
572019
Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins
W Shao, T Guo, NC Toussaint, P Xue, U Wagner, L Li, K Charmpi, Y Zhu, ...
Nature communications 10 (1), 2524, 2019
482019
Systematic characterization of pan‐cancer mutation clusters
M Buljan, P Blattmann, R Aebersold, M Boutros
Molecular systems biology 14 (3), e7974, 2018
482018
SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
W Korte, M Buljan, M Rösslein, P Wick, V Golubov, J Jentsch, M Reut, ...
The Journal of infection 82 (1), e11, 2020
442020
Polymerization in living organisms
D Wu, J Lei, Z Zhang, F Huang, M Buljan, G Yu
Chemical Society Reviews 52 (9), 2911-2945, 2023
252023
Poly (ethyl ethylene phosphate): Overcoming the “Polyethylene Glycol Dilemma” for Cancer Immunotherapy and mRNA Vaccination
X Yu, H Li, C Dong, S Qi, K Yang, B Bai, K Peng, M Buljan, X Lin, Z Liu, ...
ACS nano 17 (23), 23814-23828, 2023
72023
Proteomic-based stratification of intermediate-risk prostate cancer patients
Q Zhong, R Sun, AT Aref, Z Noor, A Anees, Y Zhu, N Lucas, RC Poulos, ...
Life Science Alliance 7 (2), 2024
62024
A computational framework for the inference of protein complex remodeling from whole-proteome measurements
M Buljan, A Banaei-Esfahani, P Blattmann, F Meier-Abt, W Shao, O Vitek, ...
Nature Methods 20 (10), 1523-1529, 2023
62023
Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer Chemoimmunotherapy
X Yu, S Qi, F Cao, K Yang, H Li, K Peng, Z Liu, B Bai, M Buljan, X Chen, ...
JACS Au 3 (11), 3181-3193, 2023
32023
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20